Sumitomo Mitsui Trust Group Inc. reduced its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 4.1% during the first quarter, Holdings Channel reports. The firm owned 936,570 shares of the semiconductor company’s stock after selling 40,352 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Synopsys were worth $371,331,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. increased its position in shares of Synopsys by 31.8% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock valued at $6,957,000 after acquiring an additional 3,575 shares during the last quarter. SeaTown Holdings Pte. Ltd. boosted its position in Synopsys by 55.9% in the fourth quarter. SeaTown Holdings Pte. Ltd. now owns 22,300 shares of the semiconductor company’s stock worth $10,475,000 after purchasing an additional 8,000 shares during the last quarter. Norges Bank bought a new position in Synopsys in the 4th quarter valued at $730,197,000. Mirae Asset Global Investments Co. Ltd. grew its stake in Synopsys by 11.3% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 131,369 shares of the semiconductor company’s stock valued at $61,707,000 after purchasing an additional 13,320 shares during the period. Finally, Douglas Lane & Associates LLC increased its position in shares of Synopsys by 5,701.2% during the 4th quarter. Douglas Lane & Associates LLC now owns 48,730 shares of the semiconductor company’s stock valued at $22,889,000 after purchasing an additional 47,890 shares during the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on SNPS shares. Needham & Company LLC reiterated a “buy” rating and set a $580.00 target price on shares of Synopsys in a research note on Thursday, May 28th. Weiss Ratings restated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. BNP Paribas Exane raised their price objective on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Bank of America lifted their price objective on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, KeyCorp reiterated an “overweight” rating on shares of Synopsys in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.
Synopsys Stock Down 0.5%
SNPS stock opened at $434.50 on Thursday. The stock has a fifty day moving average of $479.33 and a 200-day moving average of $460.96. Synopsys, Inc. has a fifty-two week low of $376.18 and a fifty-two week high of $651.73. The company has a market capitalization of $83.20 billion, a price-to-earnings ratio of 100.58, a PEG ratio of 2.56 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same period in the previous year, the business posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities research analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current year.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
